FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
-2.68%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
AUM
$483M
AUM Growth
+$483M
Cap. Flow
-$2.22M
Cap. Flow %
-0.46%
Top 10 Hldgs %
96.08%
Holding
14
New
4
Increased
1
Reduced
1
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$569M
$165M 34.09% 2,316,447 -1,372,001 -37% -$97.5M
APTX
2
DELISTED
Aptinyx Inc. Common Stock
APTX
$77.1M 15.97% +3,190,079 New +$77.1M
COLL icon
3
Collegium Pharmaceutical
COLL
$1.22B
$45M 9.32% 1,887,332
ALNA
4
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$43.4M 8.99% 3,330,373
FOLD icon
5
Amicus Therapeutics
FOLD
$2.34B
$40.6M 8.41% 2,600,014
IOVA icon
6
Iovance Biotherapeutics
IOVA
$807M
$28M 5.8% 2,188,331
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$24M 4.97% 8,112,121
ALPN
8
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$16.6M 3.45% 2,199,011
ITRM icon
9
Iterum Therapeutics
ITRM
$30.2M
$16.4M 3.4% +1,538,316 New +$16.4M
SYBX icon
10
Synlogic
SYBX
$17M
$8.08M 1.67% 821,475 +87,800 +12% +$863K
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$7.76M 1.61% +1,051,441 New +$7.76M
CDTX icon
12
Cidara Therapeutics
CDTX
$1.66B
$6.82M 1.41% 1,312,258
KZR icon
13
Kezar Life Sciences
KZR
$28.9M
$4.33M 0.9% +250,000 New +$4.33M
ARMO
14
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
-300,000 Closed -$11.2M